Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Revenue (2010 - 2026)

Palatin Technologies' (PTN) quarterly Revenue came in at $3.9 million in Q1 2026, up 3278.84% quarter-over-quarter from $116036.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Revenue (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Revenue for 14 consecutive years, with $3.9 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 3576.2% YoY), and the FY2024 full-year result was $4.5 million, down 7.49% from the prior year.
  • Revenue advanced to $3.9 million in Q1 2026 per PTN's latest filing, from $116036.0 in the prior quarter.
  • Across five years, Revenue topped out at $8.8 million in Q3 2025 and bottomed at $116036.0 in Q4 2025.
  • Historically, Revenue has averaged $1.9 million across 5 years, with a median of $1.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Revenue soared 1057.39% in 2022, then tumbled 80.14% in 2024.
  • Over 5 years, Revenue stood at $1.0 million in 2022, then jumped by 98.18% to $2.0 million in 2023, then sank by 82.79% to $350000.0 in 2024, then slumped by 66.85% to $116036.0 in 2025, then jumped by 3278.84% to $3.9 million in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $3.9 million, $116036.0, and $8.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.44 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 3.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.92 Mn
Dec 31, 2025 116,036.00
Sep 30, 2025 8.83 Mn
Jun 30, 2024 350,000.00
Dec 31, 2023 2.03 Mn
Sep 30, 2023 2.11 Mn
Jun 30, 2023 1.76 Mn
Mar 31, 2023 1.20 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 869,654.00
Jun 30, 2022 770,738.00
Mar 31, 2022 216,097.00
Dec 31, 2021 322,140.00
Sep 30, 2021 159,482.00
Jun 30, 2021 -80,504.00
Mar 31, 2021 88,741.00
Dec 31, 2020 163,971.00
Sep 30, 2020 288,560.00
Dec 31, 2019 20,610.00
Sep 30, 2019 97,379.00